A Federal Circuit court ruled that Abbott (NYSE:ABT) subsidiary St. Jude Medical must face patent infringement claims.
Just over one year ago, Abbott’s St. Jude — acquired for $25 billion in 2017 — won a patent dispute over the method for using a double catheter in heart failure patients.